Amyloid Cardiomyopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-24
Clinical Trial Update: Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy [NA]
A completed clinical trial evaluating the SGLT-2 inhibitor dapagliflozin in patients with amyloid cardiomyopathy across heart failure phenot…